SCHEMBL7716756

SCHEMBL7716756

Cc1ccccc1N1CCC(NCCNC(=O)OC(C)(C)C)CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 9/20 0.51
CHRM1 P11229 1/20 0.48
CHRM2 P08172 3/20 0.47
CHRM5 P08912 3/20 0.47
KDM4E B2RXH2 1/20 0.45
CHRM3 P20309 2/20 0.44
FAAH O00519 2/20 0.44
DRD3 P35462 2/20 0.44
EPHX1 P07099 1/20 0.43
NPY5R Q15761 1/20 0.43
PIM1 P11309 1/20 0.43
PIM3 Q86V86 1/20 0.43
PIM2 Q9P1W9 1/20 0.43
CKS1B P61024 2/20 0.42
SKP1 P63208 2/20 0.42
SKP2 Q13309 2/20 0.42
CNR1 P21554 1/20 0.42
USP2 O75604 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7716782 0.86 DRD2 (0.69) DRD2FAAHDRD3
SCHEMBL7711219 0.85 DRD2 (0.48) DRD2KDM4EDRD3EPHX1PIM1
SCHEMBL7711060 0.85 DRD2 (0.51) DRD2CHRM1CHRM2CHRM5KDM4E
SCHEMBL7711275 0.84 NPY1R (0.54) DRD2DRD3
SCHEMBL3436642 0.83 CKS1B (0.59) DRD2KDM4ECKS1BSKP1SKP2
SCHEMBL7718945 0.82 DRD2 (0.53) DRD2CKS1BSKP1SKP2
SCHEMBL7013614 0.79 ITGB3 (0.49) DRD2EPHX1CKS1BSKP1SKP2
SCHEMBL3593211 0.79 KDM4E (0.58) KDM4E
SCHEMBL7715921 0.78 FFAR4 (0.40) DRD2KDM4EDRD3EPHX1
SCHEMBL5619433 0.78 EPHX1 (0.60) DRD2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376503-B1 TREATMENT OF BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC 2002-04-23 US disclosed
EP-1023068-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 2001-05-16 EP disclosed
EP-1023068-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 2000-08-02 EP disclosed
WO-1998057638-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1998-12-23 WO disclosed